IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage
IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage
复制标题
DOI:
10.1016/s0945-053x(00)00111-6
复制
发表时间:
2000-11-01
期刊:
影响因子:
6.9
通讯作者:
Jones, SA
中科院分区:
文献类型:
--
作者:
Flannery, CR;Little, CB;Jones, SA
Elevated concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor (sIL-6R) in the synovial fluids and serum of patients with arthritis have been implicated in the joint tissue destruction associated with these conditions, however studies conducted to date on the role and effects of IL-6 in the process of cartilage proteoglycan (aggrecan) catabolism are disparate. In the present study, bovine articular cartilage explants were maintained in a model organ culture system in the presence or absence of IL-1 alpha or TNF-alpha, and under co-stimulation with or without IL-6 and/or sIL-6R. After measuring proteoglycan loss from the explants, the proteolytic activity and expression profiles of aggrecanase(s) was assessed for each culture condition. Stimulation of cartilage explants with IL-6 and/or sIL-6R potentiated aggrecan catabolism and release above that seen in the presence of IL-1 alpha or TNF-alpha alone. This catabolism was associated with aggrecanase (but not MMP) activity, with correlative mRNA expression for aggrecanase-2. (C) 2000 Elsevier Science B.V./International Society of Matrix Biology. All rights reserved.